Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delmas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 26, 2003
Anatomic variations of the arteries of the nasal fossaEmmanuel Babin, Sylvain Moreau, Marc Goullet de Rugy, et al.
Rheumatology International|June 1, 2010
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosisRené Rizzoli, Michel Laroche, Marc-Antoine Krieg, et al.
Journal of the American Geriatrics Society|October 28, 2004
Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest oldSteven Boonen, Michael R McClung, Richard Eastell, et al.
Maturitas|April 17, 2003
Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic womenOlivier Bruyere, Julien Collette, Pierre Delmas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trialDouglas C Bauer, Patrick Garnero, Marc C Hochberg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2009
Potential mediators of the mortality reduction with zoledronic acid after hip fractureCathleen S Colón-Emeric, Peter Mesenbrink, Kenneth W Lyles, et al.
Plos One|March 5, 2013
Determinants of microdamage in elderly human vertebral trabecular boneHélène Follet, Delphine Farlay, Yohann Bala, et al.
BMC Musculoskeletal Disorders|May 30, 2008
Patients with rheumatoid arthritis have an altered circulatory aggrecan profileJean C Rousseau, Eren U Sumer, Gert Hein, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosisSteven R Cummings, Javier San Martin, Michael R McClung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 9, 2005
Predictive value of BMD for hip and other fracturesOlof Johnell, John A Kanis, Anders Oden, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 26, 2003
Anatomic variations of the arteries of the nasal fossaEmmanuel Babin, Sylvain Moreau, Marc Goullet de Rugy, et al.
Rheumatology International|June 1, 2010
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosisRené Rizzoli, Michel Laroche, Marc-Antoine Krieg, et al.
Journal of the American Geriatrics Society|October 28, 2004
Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest oldSteven Boonen, Michael R McClung, Richard Eastell, et al.
Maturitas|April 17, 2003
Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic womenOlivier Bruyere, Julien Collette, Pierre Delmas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trialDouglas C Bauer, Patrick Garnero, Marc C Hochberg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2009
Potential mediators of the mortality reduction with zoledronic acid after hip fractureCathleen S Colón-Emeric, Peter Mesenbrink, Kenneth W Lyles, et al.
Plos One|March 5, 2013
Determinants of microdamage in elderly human vertebral trabecular boneHélène Follet, Delphine Farlay, Yohann Bala, et al.
BMC Musculoskeletal Disorders|May 30, 2008
Patients with rheumatoid arthritis have an altered circulatory aggrecan profileJean C Rousseau, Eren U Sumer, Gert Hein, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosisSteven R Cummings, Javier San Martin, Michael R McClung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 9, 2005
Predictive value of BMD for hip and other fracturesOlof Johnell, John A Kanis, Anders Oden, et al.
Pageof 3